International Center for Public Health (ICPH) 225 Warren Street Room 2217
Phone: (973) 972-1916
Dr. Riccardo Russo is the Director of the BSL3 Operations of the Regional Bio-containment Laboratory & Public Health Research Institute, Center for COVID-19 Response and Pandemic Preparedness (CRP2). He obtained his Ph.D. degree from the University of Florida and his MBA degree from the Auburn University. He has a certificate in Project Management and a Lean Six Sigma Green Belt. Dr. Russo is directing the four in-vitro BSL3 facility and the two animal BSL3 facilities located at the International Center for Public Health.
Since 20013, he has directed the "in vitro Antimicrobial Drug Screening Core Laboratory?, part of the Center of Excellence in Translational research (CETR), a collaborative public-private partnership involving Rutgers University and Merck (http://njms.rutgers.edu/research/cetr/) aimed at the development of a new generation of antibiotics against high-threat bacterial agents. He has directed several other projects in collaboration with research groups from different institutions, major pharma and biotech companies aimed at developing new antimicrobial compounds against ESKAPE bacteria, Mycobacterium tuberculosis, Select Agents and multi-drug resistant bacteria.
From March 2020, Dr. Russo has collaborated with academic research groups from different institutions, biotech, oral products and aerospace companies in developing new therapeutics against SARS-CoV-2 and new technologies for the sterilization of planes and medical devices.
PHD, 2004, University of Florida
Russo R., Levine C., Grady C., Peixoto B., McCormick-Ell J., Block T., Gresko A., Demas G., Chitale P., Frees A., Ruiz A. & Alland D. Decontaminating N95 respirators during the Covid-19 pandemic: simple and practical approaches to increase decontamination capacity, speed, safety and ease of use. The Journal of Hospital Infection [accepted with revisions October 2020]
Levine C., Grady C., Block T., Hurley H., Russo R., Peixoto B., Frees A., Ruiz A., Alland D. Use, reuse or discard: quantitatively defined variance in N95 respirator integrity following vaporized hydrogen peroxide decontamination during the COVID-19 pandemic. The Journal of Hospital Infection [accepted October 2020]
Rodriguez-Alvarado M., Russo R., Connell N.D. & Brenner-Moyer S.E. Design, organocatalytic synthesis, and bioactivity evaluation of enantiopure fluorinated LpxC inhibitors. Organic & Biomolecular Chemistry 18: 5867-5878, 2020
Pereira J.C., Daher S.S., Zorn K.M., Sherwood M., Russo R., Perryman A.L., Wang X., Freundlich M.J., Ekins S. & Freundlich J.S. Machine learning platform to discover novel growth inhibitors of Neisseria gonorrhoeae. Pharmaceutical Research 37(7):141, 2020
Inoyama D., Awasthi D., Capodagli G.C., Tsotetsi K., Sukheja P., Zimmerman M., Li S.G., Jadhav R., Russo R., Wang X., Grady C., Richmann T., Shrestha R, Li L., Ahn Y.M., Ho Liang H.P., Mina M., Park S., Perlin D.S., Connell N., Dartois V., Alland D., Neiditch M.B., Kumar P. & Freundlich J.S. A preclinical candidate targeting Mycobacterium tuberculosis KasA. Cell Chemical Biology 27(5):560-570, 2020
Wang X., Inoyama D., Russo R., Li S.G., Jadhav R., Stratton T.P., Mittal N., Bilotta J.A., Singleton E., Kim T., Paget S.D., Pottorf R.S., Ahn Y.M., Davila-Pagan A., Kandasamy S., Grady C., Hussain S., Soteropoulos P., Zimmerman M.D., Ho H.P., Park S., Dartois V., Ekins S., Connell N., Kumar P. & Freundlich J.S. Antitubercular triazines: optimization and intrabacterial metabolism. Cell Chemical Biology 27(2): 172-185, 2019
Russo R., Kolesnikova I., Kim T., Gupta S., Pericleous A., Kadouri D.E. & Connell N.D. Susceptibility of virulent Yersinia pestis bacteria to predator bacteria in the lungs of mice. Microorganisms 7(1):2, 2018
Perryman A.L., Patel J.S., Russo R., Singleton E., Connell N., Ekins S. & Freundlich J.S. Naive Bayesian models for Vero cell cytotoxicity. Pharmaceutical Research 35(9):170, 2018
Lane T., Russo R., Zorn K.M., Clark A.M., Korotcov A., Tkachenko V., Reynolds R.C., Perryman A.L., Freundlich JS. & Ekins S. Comparing and validating machine learning models for Mycobacterium tuberculosis. Drug Discovery Molecular Pharmaceutics, 15(10):4346-4360, 2018
Banada P., Deshpande S., Chakravorty S., Russo R., Occi J., Meister G., Jones K.J., Gelhaus C.H., Valderas M.W., Jones M., Connell N. & Alland D. Sensitive detection of Francisella tularensis directly from whole blood using the GeneXpert system. Journal of Clinical Microbiology 55(1): 291-301, 2016
21-3/31/23, Y1 $150,000, Y2